Amy Elazzouzi serves as Executive at Aura Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Amy Elazzouzi has executed 10 insider transactions totaling $65.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 20, 2026 involved selling 1,581 shares valued at $7.7K.
Amy Elazzouzi currently holds 84,081 shares of Aura Biosciences, Inc. (AURA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy Elazzouzi has been a net seller of AURA stock. They have purchased $0 and sold $65.1K worth of shares.
Amy Elazzouzi's most recent insider trade was on Jan 20, 2026, when they sold 1,581 shares at $4.86 per share.
Get notified when new Form 4 filings are submitted
| $6.35 |
| Discretionary |
| Aug 18, 2025 | AURA | $3.5K | Option Exercise | 1,094 | $3.16 | Discretionary |
| Aug 18, 2025 | AURA | $12.9K | Option Exercise | 2,554 | $5.07 | Discretionary |
| Aug 18, 2025 | AURA | $51.7K | Sale | 7,722 | $6.70 | Discretionary |
| Aug 18, 2025 | AURA | $13.0K | Option Exercise | 4,744 | $2.74 | Discretionary |
| Aug 18, 2025 | AURA | $3.0K | Option Exercise | 547 | $5.48 | Discretionary |
| Aug 18, 2025 | AURA | $2.8K | Option Exercise | 547 | $5.21 | Discretionary |
| Aug 18, 2025 | AURA | $6.0K | Option Exercise | 1,094 | $5.48 | Discretionary |
| Aug 18, 2025 | AURA | $9.9K | Option Exercise | 2,319 | $4.25 | Discretionary |